PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
18 hedge funds and large institutions have $8.79M invested in PLx Pharma Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
11% more capital invested
Capital invested by funds: $7.95M → $8.79M (+$838K)
5% less funds holding
Funds holding: 19 → 18 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$324K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$304K |
| 3 |
Goldman Sachs
New York
|
+$128K |
| 4 |
CWM
Cranbrook Wealth Management
Bloomfield Hills,
Michigan
|
+$28.2K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TTSTC
Texas Treasury Safekeeping Trust Company
Austin,
Texas
|
-$229K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$57.9K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$41K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$974 |
| 5 |
Morgan Stanley
New York
|
-$497 |
PLXP Hedge Fund Activity: Q3 2018 in Review
18 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2018, worth a combined $8.79M — up 11% from $7.95M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PLXP and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $324K. The largest seller was Texas Treasury Safekeeping Trust Company, exiting entirely with an estimated $229K sold.
- 18 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2018, down from 19 in Q2 2018.
- Funds reported $8.79M of PLx Pharma Inc. Common Stock stock for Q3 2018, up 11% quarter-over-quarter.
- 4 funds opened new PLx Pharma Inc. Common Stock positions in Q3 2018 and 5 closed out, a net change of -1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q3 2018 was Millennium Management, an estimated $324K added.
- The largest PLx Pharma Inc. Common Stock seller in Q3 2018 was Texas Treasury Safekeeping Trust Company, an estimated $229K sold.
Based on aggregated 13F filings for Q3 2018.